Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Close to 1 million US adults aged 55 years or older have active epilepsy-National Health Interview Survey, 2010, 2013, and 2015.

Sapkota S, Kobau R, Pastula DM, Zack MM.

Epilepsy Behav. 2018 Aug 2. pii: S1525-5050(18)30488-8. doi: 10.1016/j.yebeh.2018.06.030. [Epub ahead of print]

PMID:
30078516
2.

Heartland Virus and Hemophagocytic Lymphohistiocytosis in Immunocompromised Patient, Missouri, USA.

Carlson AL, Pastula DM, Lambert AJ, Staples JE, Muehlenbachs A, Turabelidze G, Eby CS, Keller J, Hess B, Buller RS, Storch GA, Byrnes K, Dehner L, Kirmani N, Kuhlmann FM.

Emerg Infect Dis. 2018 May;24(5):893-897. doi: 10.3201/eid2405.171802.

3.

Motor Abnormalities and Epilepsy in Infants and Children With Evidence of Congenital Zika Virus Infection.

Pessoa A, van der Linden V, Yeargin-Allsopp M, Carvalho MDCG, Ribeiro EM, Van Naarden Braun K, Durkin MS, Pastula DM, Moore JT, Moore CA.

Pediatrics. 2018 Feb;141(Suppl 2):S167-S179. doi: 10.1542/peds.2017-2038F. Epub 2018 Feb 1.

PMID:
29437050
4.

Multiple Strokes Associated With Elongation of the Hyoid Bone.

Ludt C, Leppert M, Jones A, Song J, Kuwayama D, Pastula DM, Poisson S.

Neurohospitalist. 2018 Jan;8(1):35-37. doi: 10.1177/1941874417706220. Epub 2017 Apr 28.

PMID:
29276562
5.
6.

Investigation of Acute Flaccid Paralysis Reported with La Crosse Virus Infection, Ohio, USA, 2008-2014.

Hennessey MJ, Pastula DM, Machesky K, Fischer M, Lindsey NP, DiOrio M, Staples JE, de Fijter S.

Emerg Infect Dis. 2017 Dec;23(12):2075-2077. doi: 10.3201/eid2312.170944.

7.

An Overview of Yellow Fever Virus Disease.

McGuinness I, Beckham JD, Tyler KL, Pastula DM.

Neurohospitalist. 2017 Oct;7(4):157-158. doi: 10.1177/1941874417708129. Epub 2017 May 10. No abstract available.

8.

Incidence and clinical characteristics of Guillain-Barré syndrome before the introduction of Zika virus in Puerto Rico.

Salinas JL, Major CG, Pastula DM, Dirlikov E, Styczynski A, Luciano CA, Wojna V, Sharp TM, Sejvar JJ, Rivera-Garcia B.

J Neurol Sci. 2017 Jun 15;377:102-106. doi: 10.1016/j.jns.2017.04.006. Epub 2017 Apr 7.

PMID:
28477675
9.

Enhanced Epilepsy Surveillance and Awareness in the Age of Zika.

Pastula DM, Yeargin-Allsopp M, Kobau R.

JAMA Neurol. 2017 Jun 1;74(6):631-632. doi: 10.1001/jamaneurol.2017.0215. No abstract available.

PMID:
28418503
10.

Chikungunya virus disease outbreak in Yap State, Federated States of Micronesia.

Pastula DM, Hancock WT, Bel M, Biggs H, Marfel M, Lanciotti R, Laven J, Chen TH, Staples JE, Fischer M, Hills SL.

PLoS Negl Trop Dis. 2017 Mar 1;11(3):e0005410. doi: 10.1371/journal.pntd.0005410. eCollection 2017 Mar.

11.

Zika Virus Disease and Associated Neurologic Complications.

Duca LM, Beckham JD, Tyler KL, Pastula DM.

Curr Infect Dis Rep. 2017 Jan;19(1):4. doi: 10.1007/s11908-017-0557-x. Review.

PMID:
28220392
12.

Zika virus disease for neurologists.

Smith DE, Beckham JD, Tyler KL, Pastula DM.

Neurol Clin Pract. 2016 Dec;6(6):515-522. doi: 10.1212/CPJ.0000000000000307. Review.

13.

Zika Virus Disease for the Neurointensivist.

Pastula DM, Durrant JC, Smith DE, Beckham JD, Tyler KL.

Neurocrit Care. 2017 Jun;26(3):457-463. doi: 10.1007/s12028-016-0333-z. Review.

PMID:
27995511
14.

Investigation of a Guillain-Barré syndrome cluster in the Republic of Fiji.

Pastula DM, Khan AS, Sharp TM, Biaukula VL, Naivalu TK, Rafai E, Ermias Belay, Staples JE, Fischer M, Kosoy OI, Laven JJ, Bennett EJ, Jenney AWJ, Naidu RN, Lanciotti RS, Galloway RL, Nilles EJ, Sejvar JJ, Kama M.

J Neurol Sci. 2017 Jan 15;372:350-355. doi: 10.1016/j.jns.2016.08.064. Epub 2016 Sep 1.

PMID:
27842986
15.

Hepatitis E Virus and Guillain-Barré Syndrome.

Tyler KL, Pastula DM.

JAMA Neurol. 2017 Jan 1;74(1):13-15. doi: 10.1001/jamaneurol.2016.3651. No abstract available.

PMID:
27820625
16.

Guillain-Barré Syndrome and Healthcare Needs during Zika Virus Transmission, Puerto Rico, 2016.

Dirlikov E, Kniss K, Major C, Thomas D, Virgen CA, Mayshack M, Asher J, Mier-Y-Teran-Romero L, Salinas JL, Pastula DM, Sharp TM, Sejvar J, Johansson MA, Rivera-Garcia B.

Emerg Infect Dis. 2017 Jan;23(1):134-136. doi: 10.3201/eid2301.161290. Epub 2017 Jan 15.

17.

Locally Acquired Eastern Equine Encephalitis Virus Disease, Arkansas, USA.

Garlick J, Lee TJ, Shepherd P, Linam WM, Pastula DM, Weinstein S, Schexnayder SM.

Emerg Infect Dis. 2016 Dec;22(12):2216-2217. doi: 10.3201/eid2212.160844. Epub 2016 Dec 15. No abstract available.

18.

Guillain-Barré Syndrome During Ongoing Zika Virus Transmission - Puerto Rico, January 1-July 31, 2016.

Dirlikov E, Major CG, Mayshack M, Medina N, Matos D, Ryff KR, Torres-Aponte J, Alkis R, Munoz-Jordan J, Colon-Sanchez C, Salinas JL, Pastula DM, Garcia M, Segarra MO, Malave G, Thomas DL, Rodríguez-Vega GM, Luciano CA, Sejvar J, Sharp TM, Rivera-Garcia B.

MMWR Morb Mortal Wkly Rep. 2016 Sep 2;65(34):910-4. doi: 10.15585/mmwr.mm6534e1.

19.

Enterovirus D68 Infection in Children with Acute Flaccid Myelitis, Colorado, USA, 2014.

Aliabadi N, Messacar K, Pastula DM, Robinson CC, Leshem E, Sejvar JJ, Nix WA, Oberste MS, Feikin DR, Dominguez SR.

Emerg Infect Dis. 2016 Aug;22(8):1387-94. doi: 10.3201/eid2208.151949.

20.

Zika Virus Infection Associated With Severe Thrombocytopenia.

Sharp TM, Muñoz-Jordán J, Perez-Padilla J, Bello-Pagán MI, Rivera A, Pastula DM, Salinas JL, Martínez Mendez JH, Méndez M, Powers AM, Waterman S, Rivera-García B.

Clin Infect Dis. 2016 Nov 1;63(9):1198-1201. Epub 2016 Jul 14.

21.

An Overview of Zika Virus Disease.

Pastula DM, Smith DE, Beckham JD, Tyler KL.

Neurohospitalist. 2016 Jul;6(3):93-4. doi: 10.1177/1941874416637409. Epub 2016 Mar 24. No abstract available.

22.

Acute Flaccid Myelitis in the United States, August-December 2014: Results of Nationwide Surveillance.

Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller L, Glaser C, Kambhampati A, Shioda K, Aliabadi N, Fischer M, Gregoricus N, Lanciotti R, Nix WA, Sakthivel SK, Schmid DS, Seward JF, Tong S, Oberste MS, Pallansch M, Feikin D.

Clin Infect Dis. 2016 Sep 15;63(6):737-745. doi: 10.1093/cid/ciw372. Epub 2016 Jun 17.

23.

Zika Virus as an Emerging Global Pathogen: Neurological Complications of Zika Virus.

Beckham JD, Pastula DM, Massey A, Tyler KL.

JAMA Neurol. 2016 Jul 1;73(7):875-9. doi: 10.1001/jamaneurol.2016.0800. Review.

24.

Four emerging arboviral diseases in North America: Jamestown Canyon, Powassan, chikungunya, and Zika virus diseases.

Pastula DM, Smith DE, Beckham JD, Tyler KL.

J Neurovirol. 2016 Jun;22(3):257-60. doi: 10.1007/s13365-016-0428-5. Epub 2016 Feb 22. Review.

25.

No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders, United States, 2001-2010.

Forrester JD, Kugeler KJ, Perea AE, Pastula DM, Mead PS.

Emerg Infect Dis. 2015 Nov;21(11):2036-9. doi: 10.3201/eid2111.150778.

26.

Adult-onset central nervous system hemophagocytic lymphohistiocytosis: a case report.

Pastula DM, Burish M, Reis GF, Bollen A, Cha S, Ralph J, Douglas VC.

BMC Neurol. 2015 Oct 14;15:203. doi: 10.1186/s12883-015-0470-6.

27.

Jamestown Canyon Virus Disease in the United States-2000-2013.

Pastula DM, Hoang Johnson DK, White JL, Dupuis AP 2nd, Fischer M, Staples JE.

Am J Trop Med Hyg. 2015 Aug;93(2):384-9. doi: 10.4269/ajtmh.15-0196. Epub 2015 Jun 1.

28.

Novel thogotovirus associated with febrile illness and death, United States, 2014.

Kosoy OI, Lambert AJ, Hawkinson DJ, Pastula DM, Goldsmith CS, Hunt DC, Staples JE.

Emerg Infect Dis. 2015 May;21(5):760-4. doi: 10.3201/eid2105.150150.

29.

Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014.

Pastula DM, Aliabadi N, Haynes AK, Messacar K, Schreiner T, Maloney J, Dominguez SR, Davizon ES, Leshem E, Fischer M, Nix WA, Oberste MS, Seward J, Feikin D, Miller L; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Oct 10;63(40):901-2.

30.

Notes from the field: Heartland virus disease - United States, 2012-2013.

Pastula DM, Turabelidze G, Yates KF, Jones TF, Lambert AJ, Panella AJ, Kosoy OI, Velez JO, Fisher M, Staples E; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Mar 28;63(12):270-1.

31.

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

Pastula DM, Moore DH, Bedlack RS.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD005225. doi: 10.1002/14651858.CD005225.pub3. Review.

PMID:
23235621
32.

Creatine for amyotrophic lateral sclerosis/motor neuron disease.

Pastula DM, Moore DH, Bedlack RS.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD005225. doi: 10.1002/14651858.CD005225.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;12:CD005225.

PMID:
20556761
33.

Factors associated with survival in the National Registry of Veterans with ALS.

Pastula DM, Coffman CJ, Allen KD, Oddone EZ, Kasarskis EJ, Lindquist JH, Morgenlander JC, Norman BB, Rozear MP, Sams LA, Sabet A, Bedlack RS.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):332-8. doi: 10.3109/17482960802320545.

PMID:
19922120
34.

Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease.

Bedlack RS, Pastula DM, Hawes J, Heydt D.

Amyotroph Lateral Scler. 2009 Aug;10(4):210-5. doi: 10.1080/17482960802430773.

PMID:
18821142
35.

Scrutinizing enrollment in ALS clinical trials: room for improvement?

Bedlack RS, Pastula DM, Welsh E, Pulley D, Cudkowicz ME.

Amyotroph Lateral Scler. 2008 Oct;9(5):257-65. doi: 10.1080/17482960802195913.

PMID:
18608092

Supplemental Content

Loading ...
Support Center